14317-68-1 ((1,6-Dicarbaoxytocin,1-butanoic acid- (9CI))

1,6-Dicarbaoxytocin,1-butanoic acid- (9CI);[Asu1,6]-Oxytocin;DEAMINO-DICARBA-OXYTOCIN;TYR-ILE-GLN-ASN-ASU-PRO-LEU-GLY-NH2: YIQN-ASU-PLG-NH2;TYR-ILE-GLN-ASN-ASU-PRO-LEU-GLY-NH2;[ASU 1,6] OT;[ASU 1,6] OXYTOCIN;oxytocin, 1,6-alpha-Asu-;CYCLO(TYR-ILE-GLN-ASN-ASU)-PRO-LEU-GLY-NH2;1-Butanoic acid-1,6-dicarbaoxytocin;DTXSID20162331;Oxytocin, 1,6-alpha-aminosuberic acid-;SCHEMBL15511850;1,6-alpha-Asu-oxytocin;14317-68-1;HY-P3866;Deaminodicarbaoxytocin;CS-0626303;1,6-alpha-Aminosuberic acid oxytocin;1,6-Dicarbaoxytocin, 1-butanoic acid-;(2S)-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]-1-[(2S,5S,8S,11S,14S)-11-(2-amino-2-oxoethyl)-8-(3-amino-3-oxopropyl)-5-[(2S)-butan-2-yl]-2-[(4-hydroxyphenyl)methyl]-3,6,9,12,20-pentaoxo-1,4,7,10,13-pentazacycloicosane-14-carbonyl]pyrrolidine-2-carboxamide;Deamino-1,6-dicarba-oxytocin;

BNUVXRORJOWJBK-DTRKZRJBSA-N

1S/C45H69N11O12/c1-5-25(4)38-44(67)51-28(17-18-34(46)58)40(63)53-32(22-35(47)59)41(64)52-29(10-7-6-8-12-37(61)50-31(42(65)55-38)21-26-13-15-27(57)16-14-26)45(68)56-19-9-11-33(56)43(66)54-30(20-24(2)3)39(62)49-23-36(48)60/h13-16,24-25,28-33,38,57H,5-12,17-23H2,1-4H3,(H2,46,58)(H2,47,59)(H2,48,60)(H,49,62)(H,50,61)(H,51,67)(H,52,64)(H,53,63)(H,54,66)(H,55,65)/t25-,28-,29-,30-,31-,32-,33-,38-/m0/s1

O=C([C@@H]1CCCCCC(N[C@@H](CC2C=CC(=CC=2)O)C(N[C@H](C(N[C@@H](CCC(N)=O)C(N[C@@H](CC(N)=O)C(N1)=O)=O)=O)[C@@H](C)CC)=O)=O)N1CCC[C@H]1C(N[C@H](C(NCC(N)=O)=O)CC(C)C)=O